Author/Creator: Liang, Sheng-Kai - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Liang, Sheng-Kai

1. Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations. (July 2019)

Authors:: Liang, Sheng-Kai; Ko, Jen-Chung; Yang, James Chih-Hsin; Shih, Jin-Yuan
Journal:: Lung cancer
Issue:: Volume 133(2019)
Page Start:: 103
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Foxm1 Transcription Factor Regulates Lung Adenocarcinoma Development. Issue 1 (May 2019)

Authors:: Liang, Sheng-Kai; Chao, Shen-Yang; Li, Chien-Cheng; Ip, Ka-U; Lin, Yi-Kai; Hsu, Chia-Chan; Hsu, Pei-Chia; Wang, I-Ching
Journal:: IOP conference series
Issue:: Volume 276:Issue 1(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells. Issue 1 (December 2016)

Authors:: Pan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; Ko, Jen-Chung; Liang, Sheng-Kai; Liang, Mei-Chih
Journal:: BMC cancer
Issue:: Volume 16:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗